A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2011
10/20/2011	US20110257257 Composition for treatment of epithelial tissue
10/20/2011	US20110257238 Heteroaryl Dihydroindolones as Kinase Inhibitors
10/20/2011	US20110257232 Biphenyl oxadiazole derivatives as sphingosine-1-phosphate receptors modulators
10/20/2011	US20110257219 Lower dosage strength pharmaceutical compositions forumlated with 3.75% imiquimod
10/20/2011	US20110257218 2 x 2 x 2 WEEK DOSING REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 3.75 % IMIQUIMOD
10/20/2011	US20110257217 3 x 3 x 3 WEEK TREATMENT REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 2.5% IMIQUIMOD
10/20/2011	US20110257216 2 x 2 x 2 WEEK TREATMENT REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 2.5% IMIQUIMOD
10/20/2011	US20110257214 Morphinan compounds
10/20/2011	US20110257208 Compounds useful as faah modulators and uses thereof
10/20/2011	US20110257200 Treatment of Acne and Other Diseases
10/20/2011	US20110257176 Nitrogen heterocycle derivatives as proteasome modulators
10/20/2011	US20110257171 Novel imidazo[1,2-a]pyridine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors
10/20/2011	US20110257170 4-morpholino-pyrido[3,2-d]pyrimidines
10/20/2011	US20110257165 Bicyclic pyrazoles as protein kinase inhibitors
10/20/2011	US20110257161 Novel diaza-bicyclononyl-phenyl derivatives and their medical use
10/20/2011	US20110257153 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase
10/20/2011	US20110257137 Heterocyclic inhibitors of histamine receptors for the treatment of disease
10/20/2011	US20110257126 Water soluble curcumin compositions for use in anti-cancer and anti-inflammatory therapy
10/20/2011	US20110257123 Aryl/alkyl vinyl sulfone hyaluronic acid derivatives
10/20/2011	US20110257110 Composition comprising a glycoside of a mono- or diacylglycerol compound and an oil rich in n-3 polyunsaturated fatty acids, a method of producing the composition and use of the composition
10/20/2011	US20110257090 Solutions for volume therapy
10/20/2011	US20110257015 Polymers, compositions and methods for use for foams, laundry detergents, shower rinses and coagulants
10/20/2011	US20110256260 Methods and compositions for synthesis of long chain polyunsaturatd fatty acids
10/20/2011	US20110256249 Hair and scalp care formulations for treating and preventing acne and related skin conditions
10/20/2011	US20110256247 Topical compositions containing nitro fatty acids
10/20/2011	US20110256239 Ingestible hair and finger nail growth promoter and method
10/20/2011	US20110256237 Methods and compositions for treating acne vulgaris and acne rosacea
10/20/2011	US20110256225 Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same
10/20/2011	US20110256222 Recombinant Protein Enriched in a Heparin Binding Site and/or in a Heparan Sulfate Binding Site
10/20/2011	US20110256202 Immunocompatible amniotic membrane products
10/20/2011	US20110256186 biomaterial based on wharton's jelly from the human umbilical cord
10/20/2011	US20110256185 Reinforced tissue shields
10/20/2011	US20110256171 Novel use of l. undulata extract as therapeutics for allergic diseases
10/20/2011	US20110256160 Adherent cells from placenta tissue and use thereof in therapy
10/20/2011	US20110256149 Antibody formulation
10/20/2011	US20110256142 Novel methods and antibodies for treating cancer
10/20/2011	US20110256132 Myostatin binding proteins
10/20/2011	US20110256130 Methods of treating inflammatory disorders
10/20/2011	US20110256126 IL-17A/F Heterologous Polypeptides and Therapeutic Uses Thereof
10/20/2011	US20110256115 Hydrosoluble [6)o-alpha-d-glcp-(1->]n-6-o-beta-d-glcp-(1->-phenolic derivatives with dermocosmetic, nutritional and therapeutic applications, and compositions containing said water soluble compounds
10/20/2011	US20110256091 Antibody-Targeted Cytokines for Therapy
10/20/2011	US20110256078 Cosmetic/dermatological compositions comprising naphtholic acid compounds and polyurethane polymers
10/20/2011	US20110256061 Binding agents to the Integrin Alpha-11 subunit, and uses thereof
10/20/2011	DE102010015793A1 Active agent combination, useful in preparation, preferably cosmetic or dermatological preparation to treat dermatoses, comprises magnolia bark extract containing magnolol and/or honokiol, and surface- or interface-active phosphoric esters
10/20/2011	DE102010015792A1 Wirkstoffkombinationen aus Magnolienrindenextrakt und oberflächenaktiven Agentien Active compound combinations of Magnolia Bark Extract and surface active agents
10/20/2011	CA2796334A1 Compositions with reactive ingredients, and wound dressings, apparatuses, and methods
10/20/2011	CA2796311A1 Fused derivatives as pi3k.delta. inhibitors
10/20/2011	CA2796068A1 Anti-bacterial applications of poly-n-acetylglucosamine nanofibers
10/20/2011	CA2793451A1 Aptamers to .beta.-ngf and their use in treating .beta.-ngf mediated diseases and disorders
10/20/2011	CA2769678A1 Extracts of poria cocos and phragmites kharka
10/19/2011	EP2377875A1 Antioxidant
10/19/2011	EP2377865A1 Cyclobutyl purine derivative, angiogenesis promoting agent, lumenization promoting agent, neurocyte growth promoting agent, and drug
10/19/2011	EP2377851A1 Isoquinoline derivative
10/19/2011	EP2377850A1 TRPV1 vanilloid receptor antagonists with a bicyclic portion
10/19/2011	EP2377558A2 Composition for improving inflammatory disease using abh antigens
10/19/2011	EP2377541A1 Use of chitosans to increase nail growth rate
10/19/2011	EP2377532A1 Cosmetic and pharmaceutical compositions comprising ACE inhibitors and/or angiotensin II receptor antagonists for treating dermatological disorders
10/19/2011	EP2376633A1 Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis
10/19/2011	EP2376536A2 Remedies for pemphigus containing anti fas ligand antibodies
10/19/2011	EP2376510A1 Novel aryl c-xyloside compounds, and cosmetic use
10/19/2011	EP2376198A2 A composition comprising a retinoid and method of treating skin conditions
10/19/2011	EP2376103A1 Cyclosporine compositions for enhancing nail growth
10/19/2011	EP2376102A1 Compositions for enhancing nail growth
10/19/2011	EP2376095A2 Combinations of herb extracts having synergistic antioxidant effect, and methods relating thereto
10/19/2011	EP2376056A1 Cosmetic and pharmaceutical formulations of calixarene molecules
10/19/2011	EP2221377B1 Oligonucleotide compositions with enhanced efficiency
10/19/2011	EP1762610B1 Truncated dance, dance complex and method of using these
10/19/2011	EP1595936B1 Composition for external use
10/19/2011	EP1499613B1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/19/2011	EP1405560B1 Il-18 transgenic animal
10/19/2011	EP1139974B1 Soy depigmenting and skin care compositions
10/19/2011	EP1084708B1 Method of processing medicated bath liquor of natural plant into medicinal powder
10/19/2011	EP1041982B1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/19/2011	CN102224142A Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
10/19/2011	CN102224139A Novel 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
10/19/2011	CN102223889A Homeopathic therapeutic method
10/19/2011	CN102223884A Solid pharmaceutical composition
10/19/2011	CN102218132A Medicinal composition for treating nasal bleeding
10/19/2011	CN102218131A External Chinese herbal medicine composition for promoting tissue regeneration and knitting bones
10/19/2011	CN102218118A Ointment for treating anal fissure and preparation method thereof
10/19/2011	CN102218112A Formula of Chinese herbal medicine for lipsotrichia stopping and hair growth and preparation method thereof
10/19/2011	CN102218105A Medicinal liquor for treating psoriasis and method for producing same
10/19/2011	CN102218094A Chinese medicinal preparation for treating traumatic injury and preparation method thereof
10/19/2011	CN102218090A Rice roasting processing method of traditional Chinese medicine salvia miltiorrhiza bunge
10/19/2011	CN102218085A Quality control method for leaves of lithocarpus litseifolius(Hance)Chun as medicinal material
10/19/2011	CN102218079A Biological colloid dispersant used for wound-protection and its preparation method
10/19/2011	CN102218053A Application of luteolin in preparation of medicaments for inhibiting angiogenesis
10/19/2011	CN102218048A Application of magnolol in preparation of external preparations and daily chemical products for treating dermatosis caused by malassezia
10/19/2011	CN102218041A Ebastine solid dispersion and high-dissolubility ebastine tablet prepared by the same
10/19/2011	CN102217757A Plant superoxide dismutase buccal tablets and preparation method thereof
10/19/2011	CN101890080B Hair-loss preventing and hair-restoring medicinal composition and preparation method thereof, shampoo containing medicinal composition and preparation method thereof
10/19/2011	CN101785766B Lidocaine and chlorhexidine aerosol
10/19/2011	CN101696205B 3-(substituted xylylenimine-2-yl)-2,6-dioxopiperidine polymorph and pharmaceutical composition
10/19/2011	CN101549092B Quality control method of toxicant elimination and fat cleanness tablet
10/19/2011	CN101528215B Compositions of chk1 inhibitors and cyclodextrin
10/19/2011	CN101439151B Medicament for treating beriberi
10/18/2011	US8039444 Antisense permeation enhancers
10/18/2011	US8039026 Methods for treating skin pigmentation
10/18/2011	US8039012 Topical compositions for anti-aging and methods of using same
10/18/2011	US8038988 Method of enhancing hair growth

1 ... 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 ... 1065